Showing results (81-90 of 173) with videos related to

Sort By:
Pageof 18
Lasers in Medical Science|March 13, 2021
Retroperitoneoscopic partial nephrectomy using a 980/1470-nm dual-diode laser for small exophytic renal tumorsJie Dong, Weifeng Xu, Guanghua Liu, et al.
International Journal of Oncology|April 23, 2020
Tetramethylpyrazine reduces prostate cancer malignancy through inactivation of the DPP10‑AS1/CBP/FOXM1 signaling pathwayYi Zhou, Zhien Zhou, Zhigang Ji, et al.
Oncology Reports|September 20, 2024
[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1Yi Zhou, Zhigang Ji, Weigang Yan, et al.
Cancer Biology & Therapy|November 22, 2018
Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1Guanghua Liu, Xin Zhao, Jingmin Zhou, et al.
Disease Markers|January 29, 2021
A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell CarcinomaJingmin Zhou, Guanghua Liu, Xingcheng Wu, et al.
Annals of Vascular Surgery|November 5, 2011
Surgical treatment of renal artery compression by diaphragmatic crusXiaojun Song, Qi Liu, Yuehong Zheng, et al.
Oncology Letters|July 11, 2019
<sup>125</sup>I low-dose-rate prostate brachytherapy and radical prostatectomy in patients with prostate cancerZhien Zhou, Weigang Yan, Yi Zhou, et al.
Frontiers in Immunology|September 5, 2022
Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancerHualin Chen, Wenjie Yang, Xiaoqiang Xue, et al.
Plos One|February 4, 2015
Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinomaYushi Zhang, Yongqiang Li, Jianhua Deng, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 14, 2015
[Analysis of permanent brachytherapy combined with maximal androgen blockade in local intermediated-risk prostate cancer]Yi Zhou, Hanzhong Li, Weigang Yan, et al.
Pageof 18